Characteristics | Total n = 1360 |
---|---|
Age, years, median (IQR) | 55 (46–65) |
Female sex | 408 (30%) |
Histology subtype | |
 ccRCC | 1228 (90.29%) |
 non-ccRCC | 132 (9.71%) |
Location | |
 left | 626 (46.03%) |
 right | 697 (51.25%) |
 bilateral | 37 (2.72%) |
Fuhrman grade | |
 1 | 374 (27.5%) |
 2 | 738 (54.26%) |
 3 | 237 (17.43%) |
 4 | 11 (0.81%) |
T-stage | |
 1 | 1015 (74.63%) |
 2 | 113 (8.32%) |
 3 | 225 (16.54%) |
 4 | 7 (0.51%) |
N status | |
 negative | 1327 (97.57%) |
 positive | 33 (2.43%) |
ASA grade | |
 1 | 192 (14.12%) |
 2 | 1072 (78.82%) |
 3&4 | 96 (7.06%) |
Sarcomatoid transformation | 65 (4.78%) |
Metastasis | 61 (4.48%) |
Lymphovascular invasion | 100 (7.35%) |
Necrosis | 419 (3.08%) |
Hypoalbuminemia | 53 (3.9%) |
Anemia | 267 (19.6%) |
NLR, median (IQR) | 2.13 (1.60–2.85) |
PLR, median (IQR) | 124.07 (97.33–165.22) |
HALP, median (IQR) | 47.48 (33.21–63.45) |